The global market for Custom Recombinant Protein Expression Service was valued at US$ 1827 million in the year 2024 and is projected to reach a revised size of US$ 2607 million by 2031, growing at a CAGR of 5.2% during the forecast period.
A custom recombinant protein expression service is a specialized biotechnology offering that involves the design, production, and purification of proteins tailored to specific research, industrial, or therapeutic needs. The process begins with cloning the gene of interest into a suitable expression vector (e.g., bacterial, yeast, insect, or mammalian cell systems), which is then introduced into host cells to drive protein synthesis. Services are highly customizable, allowing clients to specify parameters such as cell type, expression scale (laboratory to industrial), post-translational modifications (e.g., glycosylation, phosphorylation), and purification requirements (e.g., tag removal, endotoxin levels). These services are critical for applications ranging from antibody development and enzyme production to structural biology studies and drug discovery, as they enable the generation of proteins that may be difficult to isolate from natural sources or require specific functional properties. Providers often leverage advanced technologies like CRISPR-mediated genome editing, codon optimization, and high-throughput screening to enhance expression efficiency and protein quality, ensuring reliable, reproducible results for academic, biotech, and pharmaceutical clients.
The custom recombinant protein expression service industry is currently witnessing several notable trends. Firstly, there is a continuous expansion in market size. Driven by the booming biopharmaceutical industry, the demand for high - quality recombinant proteins in drug development, such as for therapeutic antibodies, enzyme replacement therapies, and vaccines, is surging. Secondly, technological innovation is a key trend. Advanced gene - editing technologies like CRISPR - Cas9 are being increasingly adopted, enabling more precise and efficient manipulation of genes for recombinant protein production. This not only improves the production yield but also enhances the quality and functionality of the proteins. Additionally, there is a growing focus on optimizing cell factories through genetic engineering. By modifying host cells, companies can achieve higher levels of protein expression and better - controlled product quality. Automation and digitization are also making inroads. Automated equipment streamlines the production process, reducing human error and increasing throughput, while digital management systems help in better tracking, monitoring, and controlling of the entire production workflow, leading to cost - effective production. Another significant trend is the rising demand for personalized services. As different research projects and biopharmaceutical applications have unique requirements for recombinant proteins, service providers are now offering more customized solutions. This includes tailoring the expression system (such as choosing from mammalian, bacterial, insect, or yeast systems based on the specific needs of the protein), optimizing purification methods, and even custom - designing fusion tags to enhance protein solubility and ease of purification.
This report aims to provide a comprehensive presentation of the global market for Custom Recombinant Protein Expression Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Recombinant Protein Expression Service.
The Custom Recombinant Protein Expression Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Custom Recombinant Protein Expression Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Custom Recombinant Protein Expression Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Sino Biological
CUSABIO
ProteoGenix
VectorBuilder Inc
Biocompare
Biomatik
Boster Bio
Eurofins Discovery
MedChemExpress
ProMab
Rapid Novor
BIOZOL
Thermo Fisher Scientific
Bio-Techne
LifeTein
RayBiotech
OriGene
trenzyme
Segment by Type
Prokaryotic Expression Service
Yeast Expression Services
Insect Cell Expression Services
Mammalian Cell Expression Services
Extracellular Expression Service
Segment by Application
Biomedicine
Food Science and Technology
Agricultural Science and Technology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Recombinant Protein Expression Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Recombinant Protein Expression Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prokaryotic Expression Service
1.2.3 Yeast Expression Services
1.2.4 Insect Cell Expression Services
1.2.5 Mammalian Cell Expression Services
1.2.6 Extracellular Expression Service
1.3 Market by Application
1.3.1 Global Custom Recombinant Protein Expression Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Food Science and Technology
1.3.4 Agricultural Science and Technology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Recombinant Protein Expression Service Market Perspective (2020-2031)
2.2 Global Custom Recombinant Protein Expression Service Growth Trends by Region
2.2.1 Global Custom Recombinant Protein Expression Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Custom Recombinant Protein Expression Service Historic Market Size by Region (2020-2025)
2.2.3 Custom Recombinant Protein Expression Service Forecasted Market Size by Region (2026-2031)
2.3 Custom Recombinant Protein Expression Service Market Dynamics
2.3.1 Custom Recombinant Protein Expression Service Industry Trends
2.3.2 Custom Recombinant Protein Expression Service Market Drivers
2.3.3 Custom Recombinant Protein Expression Service Market Challenges
2.3.4 Custom Recombinant Protein Expression Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Recombinant Protein Expression Service Players by Revenue
3.1.1 Global Top Custom Recombinant Protein Expression Service Players by Revenue (2020-2025)
3.1.2 Global Custom Recombinant Protein Expression Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Custom Recombinant Protein Expression Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Custom Recombinant Protein Expression Service Revenue
3.4 Global Custom Recombinant Protein Expression Service Market Concentration Ratio
3.4.1 Global Custom Recombinant Protein Expression Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Recombinant Protein Expression Service Revenue in 2024
3.5 Global Key Players of Custom Recombinant Protein Expression Service Head office and Area Served
3.6 Global Key Players of Custom Recombinant Protein Expression Service, Product and Application
3.7 Global Key Players of Custom Recombinant Protein Expression Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Recombinant Protein Expression Service Breakdown Data by Type
4.1 Global Custom Recombinant Protein Expression Service Historic Market Size by Type (2020-2025)
4.2 Global Custom Recombinant Protein Expression Service Forecasted Market Size by Type (2026-2031)
5 Custom Recombinant Protein Expression Service Breakdown Data by Application
5.1 Global Custom Recombinant Protein Expression Service Historic Market Size by Application (2020-2025)
5.2 Global Custom Recombinant Protein Expression Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Custom Recombinant Protein Expression Service Market Size (2020-2031)
6.2 North America Custom Recombinant Protein Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Custom Recombinant Protein Expression Service Market Size by Country (2020-2025)
6.4 North America Custom Recombinant Protein Expression Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Recombinant Protein Expression Service Market Size (2020-2031)
7.2 Europe Custom Recombinant Protein Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Custom Recombinant Protein Expression Service Market Size by Country (2020-2025)
7.4 Europe Custom Recombinant Protein Expression Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Recombinant Protein Expression Service Market Size (2020-2031)
8.2 Asia-Pacific Custom Recombinant Protein Expression Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Custom Recombinant Protein Expression Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Custom Recombinant Protein Expression Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Recombinant Protein Expression Service Market Size (2020-2031)
9.2 Latin America Custom Recombinant Protein Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Custom Recombinant Protein Expression Service Market Size by Country (2020-2025)
9.4 Latin America Custom Recombinant Protein Expression Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Recombinant Protein Expression Service Market Size (2020-2031)
10.2 Middle East & Africa Custom Recombinant Protein Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Custom Recombinant Protein Expression Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Custom Recombinant Protein Expression Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Custom Recombinant Protein Expression Service Introduction
11.1.4 GenScript Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Sino Biological
11.2.1 Sino Biological Company Details
11.2.2 Sino Biological Business Overview
11.2.3 Sino Biological Custom Recombinant Protein Expression Service Introduction
11.2.4 Sino Biological Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.2.5 Sino Biological Recent Development
11.3 CUSABIO
11.3.1 CUSABIO Company Details
11.3.2 CUSABIO Business Overview
11.3.3 CUSABIO Custom Recombinant Protein Expression Service Introduction
11.3.4 CUSABIO Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.3.5 CUSABIO Recent Development
11.4 ProteoGenix
11.4.1 ProteoGenix Company Details
11.4.2 ProteoGenix Business Overview
11.4.3 ProteoGenix Custom Recombinant Protein Expression Service Introduction
11.4.4 ProteoGenix Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.4.5 ProteoGenix Recent Development
11.5 VectorBuilder Inc
11.5.1 VectorBuilder Inc Company Details
11.5.2 VectorBuilder Inc Business Overview
11.5.3 VectorBuilder Inc Custom Recombinant Protein Expression Service Introduction
11.5.4 VectorBuilder Inc Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.5.5 VectorBuilder Inc Recent Development
11.6 Biocompare
11.6.1 Biocompare Company Details
11.6.2 Biocompare Business Overview
11.6.3 Biocompare Custom Recombinant Protein Expression Service Introduction
11.6.4 Biocompare Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.6.5 Biocompare Recent Development
11.7 Biomatik
11.7.1 Biomatik Company Details
11.7.2 Biomatik Business Overview
11.7.3 Biomatik Custom Recombinant Protein Expression Service Introduction
11.7.4 Biomatik Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.7.5 Biomatik Recent Development
11.8 Boster Bio
11.8.1 Boster Bio Company Details
11.8.2 Boster Bio Business Overview
11.8.3 Boster Bio Custom Recombinant Protein Expression Service Introduction
11.8.4 Boster Bio Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.8.5 Boster Bio Recent Development
11.9 Eurofins Discovery
11.9.1 Eurofins Discovery Company Details
11.9.2 Eurofins Discovery Business Overview
11.9.3 Eurofins Discovery Custom Recombinant Protein Expression Service Introduction
11.9.4 Eurofins Discovery Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.9.5 Eurofins Discovery Recent Development
11.10 MedChemExpress
11.10.1 MedChemExpress Company Details
11.10.2 MedChemExpress Business Overview
11.10.3 MedChemExpress Custom Recombinant Protein Expression Service Introduction
11.10.4 MedChemExpress Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.10.5 MedChemExpress Recent Development
11.11 ProMab
11.11.1 ProMab Company Details
11.11.2 ProMab Business Overview
11.11.3 ProMab Custom Recombinant Protein Expression Service Introduction
11.11.4 ProMab Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.11.5 ProMab Recent Development
11.12 Rapid Novor
11.12.1 Rapid Novor Company Details
11.12.2 Rapid Novor Business Overview
11.12.3 Rapid Novor Custom Recombinant Protein Expression Service Introduction
11.12.4 Rapid Novor Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.12.5 Rapid Novor Recent Development
11.13 BIOZOL
11.13.1 BIOZOL Company Details
11.13.2 BIOZOL Business Overview
11.13.3 BIOZOL Custom Recombinant Protein Expression Service Introduction
11.13.4 BIOZOL Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.13.5 BIOZOL Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Custom Recombinant Protein Expression Service Introduction
11.14.4 Thermo Fisher Scientific Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 Bio-Techne
11.15.1 Bio-Techne Company Details
11.15.2 Bio-Techne Business Overview
11.15.3 Bio-Techne Custom Recombinant Protein Expression Service Introduction
11.15.4 Bio-Techne Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.15.5 Bio-Techne Recent Development
11.16 LifeTein
11.16.1 LifeTein Company Details
11.16.2 LifeTein Business Overview
11.16.3 LifeTein Custom Recombinant Protein Expression Service Introduction
11.16.4 LifeTein Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.16.5 LifeTein Recent Development
11.17 RayBiotech
11.17.1 RayBiotech Company Details
11.17.2 RayBiotech Business Overview
11.17.3 RayBiotech Custom Recombinant Protein Expression Service Introduction
11.17.4 RayBiotech Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.17.5 RayBiotech Recent Development
11.18 OriGene
11.18.1 OriGene Company Details
11.18.2 OriGene Business Overview
11.18.3 OriGene Custom Recombinant Protein Expression Service Introduction
11.18.4 OriGene Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.18.5 OriGene Recent Development
11.19 trenzyme
11.19.1 trenzyme Company Details
11.19.2 trenzyme Business Overview
11.19.3 trenzyme Custom Recombinant Protein Expression Service Introduction
11.19.4 trenzyme Revenue in Custom Recombinant Protein Expression Service Business (2020-2025)
11.19.5 trenzyme Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
GenScript
Sino Biological
CUSABIO
ProteoGenix
VectorBuilder Inc
Biocompare
Biomatik
Boster Bio
Eurofins Discovery
MedChemExpress
ProMab
Rapid Novor
BIOZOL
Thermo Fisher Scientific
Bio-Techne
LifeTein
RayBiotech
OriGene
trenzyme
听
听
*If Applicable.
